DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Clemmons DR, Miller S, Mamputu JC.
Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: a randomized, placebo-controlled trial.
PLoS One 2017;
12 (06) e0179538
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.